blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3518897

EP3518897 - OPHTHALMIC DRUG SUSTAINED RELEASE FORMULATION AND USES THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  16.12.2022
Database last updated on 15.06.2024
FormerThe patent has been granted
Status updated on  07.01.2022
FormerGrant of patent is intended
Status updated on  23.08.2021
FormerRequest for examination was made
Status updated on  05.07.2019
FormerThe international publication has been made
Status updated on  07.04.2018
Most recent event   Tooltip31.05.2024Lapse of the patent in a contracting state
New state(s): MK		published on 03.07.2024 [2024/27]
Applicant(s)For all designated states
Mati Therapeutics Inc.
4317 Dunning Lane
Austin, TX 78746 / US
[2019/32]
Inventor(s)01 / UTKHEDE, Deepank
201-4475 Wayburne Drive
Burnaby, British Columbia V5G 4X4 / CA
02 / JONES, Catherine
201-4475 Wayburne Drive
Burnaby, British Columbia V5G 4X4 / CA
03 / WISEMAN, David
201-4475 Wayburne Drive
Burnaby, British Columbia V5G 4X4 / CA
 [2019/32]
Representative(s)HGF
HGF Limited
1 City Walk
Leeds LS11 9DX / GB
[2022/06]
Former [2019/32]HGF Limited
1 City Walk
Leeds LS11 9DX / GB
Application number, filing date17857601.330.09.2017
[2019/32]
WO2017US54654
Priority number, dateUS201662402938P30.09.2016         Original published format: US 201662402938 P
[2019/32]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018064648
Date:05.04.2018
Language:EN
[2018/14]
Type: A1 Application with search report 
No.:EP3518897
Date:07.08.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 05.04.2018 takes the place of the publication of the European patent application.
[2019/32]
Type: B1 Patent specification 
No.:EP3518897
Date:09.02.2022
Language:EN
[2022/06]
Search report(s)International search report - published on:US05.04.2018
(Supplementary) European search report - dispatched on:EP29.04.2020
ClassificationIPC:A61K9/14, A61K47/34, A61K47/10, A61K31/165, A61K38/13, A61F9/00, A61L27/54
[2020/22]
CPC:
A61K9/0048 (EP); A61K9/0051 (EP,KR,US); A61F9/0017 (EP,KR,US);
A61F9/00772 (EP,KR,US); A61K31/136 (KR); A61K31/165 (EP,US);
A61K31/192 (EP); A61K31/405 (EP); A61K31/569 (US);
A61K31/573 (EP,KR,US); A61K31/60 (KR); A61K38/13 (EP,US);
A61K47/10 (EP,KR,US); A61K47/26 (EP); A61K47/34 (EP,KR,US);
A61K9/0092 (EP); A61K9/146 (EP,US); A61P27/04 (EP);
A61P27/06 (EP,KR); A61P27/12 (EP) (-)
Former IPC [2019/32]A61K9/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/32]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:AUGENMEDIKATION MIT VERZÖGERTER FREISETZUNG UND VERWENDUNG DAVON[2019/32]
English:OPHTHALMIC DRUG SUSTAINED RELEASE FORMULATION AND USES THEREOF[2019/32]
French:FORMULATION OPHTALMIQUE À LIBÉRATION PHARMACOLOGIQUE PROLONGÉE ET SES UTILISATIONS[2019/32]
Entry into regional phase29.04.2019National basic fee paid 
29.04.2019Search fee paid 
29.04.2019Designation fee(s) paid 
29.04.2019Examination fee paid 
Examination procedure29.04.2019Examination requested  [2019/32]
11.01.2021Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
19.03.2021Amendment by applicant (claims and/or description)
24.08.2021Communication of intention to grant the patent
24.12.2021Fee for grant paid
24.12.2021Fee for publishing/printing paid
24.12.2021Receipt of the translation of the claim(s)
Divisional application(s)EP22152097.6  / EP4046609
Opposition(s)10.11.2022No opposition filed within time limit [2023/03]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
19.03.2021Request for further processing filed
19.03.2021Full payment received (date of receipt of payment)
Request granted
01.04.2021Decision despatched
Fees paidRenewal fee
29.04.2019Renewal fee patent year 03
28.09.2020Renewal fee patent year 04
27.09.2021Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU30.09.2017
AL09.02.2022
CY09.02.2022
CZ09.02.2022
EE09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
MC09.02.2022
MK09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SI09.02.2022
SK09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
IE30.09.2022
LU30.09.2022
[2024/27]
Former [2024/21]HU30.09.2017
AL09.02.2022
CY09.02.2022
CZ09.02.2022
EE09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
MC09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SI09.02.2022
SK09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
IE30.09.2022
LU30.09.2022
Former [2024/18]HU30.09.2017
AL09.02.2022
CZ09.02.2022
EE09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
MC09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SI09.02.2022
SK09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
IE30.09.2022
LU30.09.2022
Former [2023/33]AL09.02.2022
CZ09.02.2022
EE09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
MC09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SI09.02.2022
SK09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
IE30.09.2022
LU30.09.2022
Former [2023/30]AL09.02.2022
CZ09.02.2022
EE09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
MC09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SI09.02.2022
SK09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
LU30.09.2022
Former [2023/22]AL09.02.2022
CZ09.02.2022
EE09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
MC09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SI09.02.2022
SK09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
Former [2023/10]AL09.02.2022
CZ09.02.2022
EE09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SI09.02.2022
SK09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
Former [2023/01]AL09.02.2022
CZ09.02.2022
EE09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SK09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
Former [2022/49]CZ09.02.2022
EE09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SK09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
Former [2022/48]CZ09.02.2022
EE09.02.2022
FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
Former [2022/47]FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
PL09.02.2022
RO09.02.2022
RS09.02.2022
SM09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
Former [2022/42]FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
PL09.02.2022
RS09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
IS09.06.2022
PT09.06.2022
Former [2022/39]FI09.02.2022
HR09.02.2022
LT09.02.2022
LV09.02.2022
PL09.02.2022
RS09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
PT09.06.2022
Former [2022/36]HR09.02.2022
LT09.02.2022
LV09.02.2022
PL09.02.2022
RS09.02.2022
BG09.05.2022
NO09.05.2022
GR10.05.2022
PT09.06.2022
Former [2022/35]HR09.02.2022
LT09.02.2022
RS09.02.2022
BG09.05.2022
NO09.05.2022
PT09.06.2022
Former [2022/34]LT09.02.2022
NO09.05.2022
PT09.06.2022
Former [2022/33]LT09.02.2022
NO09.05.2022
Documents cited:Search[X]US2008107694  (TROGDEN JOHN T [US], et al) [X] 1-19 * paragraphs [0010] , [0011] , [0012]; figure 1; example 4 *;
 [Y]US2009196905  (SPADA LON T [US], et al) [Y] 1-19 * paragraph [0103] *;
 [X]US2015133546  (BUTUNER ZUHAL [CA], et al) [X] 1-19 * paragraphs [0080] , [0109] , [0124] , [0191] , [0266] , [0287]; figure - *;
 [Y]  - NG XU WEN ET AL, "A biodegradable ocular implant for long-term suppression of intraocular pressure", DRUG DELIVERY AND TRANSLATIONAL RESEARCH, SPRINGER, GERMANY, vol. 5, no. 5, doi:10.1007/S13346-015-0240-4, ISSN 2190-393X, (20150623), pages 469 - 479, (20150623), XP035530672 [Y] 1-19 * figure - *

DOI:   http://dx.doi.org/10.1007/s13346-015-0240-4
International search[Y]EP0179583  (MERCK & CO INC [US]) [Y] 92-103 * The entire document, and more specifically: pg 5, In 20-21 and In 29-32; pg 6, In 20-30; pg 8, In 22-29; pg 9, In 28-35; pg 10, In 1-13; pg 11, In 12-23; pg 13, In 21-34; claims 2-3; abstract *;
 [Y]US5632773  (GRAHAM RICHARD S [US], et al) [Y] 90-91 * col 1, In 43-48; col 3, In 29-43 *;
 [Y]WO9951201  (SUNSCAPE DEVELOPMENTS LIMITED [NZ], et al) [Y] 37, 41-42, 59-60 and 65- 91 * The entire document, and more specifically: pg 2, In 16-18; pg 3, In 28-31; pg 4, In 1-3 and In 22 -32; abstract *;
 [Y]US2007280992  (MARGARON PHILIPPE M C [CA], et al) [Y] 1-64 * The entire document, and more specifically: para [0006]-[0007], [0009]-[0010], [0017], [0019], [0022], [0073], [0084], [0117], [0119]-[0120], [0156], [0208]; abstract *;
 [Y]US2009196905  (SPADA LON T [US], et al) [Y] 58-64 * para [0035], [0046], [0053], [0072], [0103] *;
 [Y]US2011054031  (MCNAMARA TIM [US], et al) [Y] 20-21, 56-57 and 81 * para [0010], [0055], [0077], [0097], [0110], [0116], [0123], [0134] *;
 [Y]US2015105468  (MARTINEZ-ALZAMORA FERNANDO [ES], et al) [Y] 102* para [0002], [0004], [0109]-[0110], [0115]-[0116] *;
 [Y]US2015133546  (BUTUNER ZUHAL [CA], et al) [Y] 1-55, 62-63 and 65-103 * para [0002], [0006], [0009]-[0010], [0012], [0023], [0032], [0040], [0042], [0074], [0077], [0079]-[0080], [0083]-[0084], [0087], [0090], [0101], [0109], [0126], [0131], [0135], [0137], [0160], [0162], [0164], [0168]-[0169], [0196], [0229], [0251], [0264], [0266], [0274]; claim 124; figures 2A -2B *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.